Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not buying anymore until this bottoms out somewhere around 6.00
From their last 10Q about patent infringement by TauroPharm, "An oral hearing has been scheduled for September 17, 2019."
It also mentions a hearing on Sept 6th. Not sure which date is final.
http://irdirect.net/filings/viewer/index/1410098/000165495419009628/
More news soon?
Agreed. I kept my initial position in the event of partnership or BO but pulled the rest.
Don’t expect catalyst until 2020. Chew and Khoso played fast and loose with possible LPAD dates last year. Shame on them, IMO.
Wouldn't be a surprise if we saw it coming. Lots could happen, massive buyout, big Pharma pays huge premium, partnership, who knows. But nothing really expected till early next year.
and no real chance for some kind of upside surprise between now and then either
According to Q2 transcript FDA meeting in 4Q 2019 to discuss CMC information in prep for preNDA meeting. Probably nothing big released till after that. Probably not much then either. No big news till after the pre NDA meeting early next year.
kinda getting the doo-doo treatment here lately - crmd needs some news soon. investors are just getting tired of waiting around
getting interesting now..
Thought the CC went well, nice update on things. Then this activity..
Sounds like the pieces are 'coming together'...
Question is, what will the final 'picture' look like... (although $8 pre-split was my original target as they moved towards approval, would like to see $20 now as a minimum for holding)
Cormedix enters Exchange Agreement with Elliott Associates
Looks like CRMD is cleaning up the company shares. Might be to make the company more attractive for either a partnership or buyout. Wonder if something is in the works.
Janey - I don't agree but many do seem to have that opinion. Good luck to you!
My quick take on yesterday's call:
Perfect call for institutions IMO. Retail hears a year before NDA, tutes hear very high likelihood of success with no need to raise capital.
No comparison whatsoever, but think Tesla or Beyond meat. Yes they have revenue, but they loose cash consistently. Tutes are heavy here cause they know (or have a great expectation anyway) that the future is bright. When do the huge drops happen.....capital raises. Tutes are going to be more than happy to let retail panic, day traders do their thing, and let shorts play while they steadily accumulate. I really believe we are heading into a new territory in the next 6-9 months (maybe sooner) when tutes will determine the stock volatility and not retail. Does that mean we get rich today or tomorrow...no. The PPS can go way up or way down....if I had to guess, I would bet it will do both at some point. Perfect for day traders..... that's just not my game and I won't try to guess near term fluctuations.
But what I do think.
1. CRMD is highly confident, that is obvious.
2. Why the little anecdote about bringing in a more experienced, BF type player to partner with oncology? I think they have a plan in process.
3. My valuation has only increased. Just the 40M hd locks is huge.
I am, have been, and remain bullish. Everything above are my opinions only. Notice I said "think or believe" a lot as I don't know anything!!!
Good luck all!
Short answer is no, but things to consider about Cormedix and other similar companies. There is a relatively high retail investor presence with high expectations of what is going to happen tomorrow or today or in the next hour. Many are playing with scared money and sell when they start seeing a down trend or start Cadillac shopping when there is an uptrend. This makes the stock prone for big swings inviting day traders to the party. This creates great opportunities for shorts to play the game. Most wild pre and post movement swings are on a few shares. Is this MM sending signals to each other, a retail investor scared and dumping his/her 50 shares, or a retail investor buying way to high cause sticktwits says it's going to the moon? Who knows, but I don't care about meaningless swings myself. This type of movement will only stop once the volatility slows or there is a much higher institutional stake. Tutes seem to be buying in Q2. If their holdings can eventually get to 50% or so, the games you see will slow. Right now, I think everyone can make money here.....traders, shorts, and longs......pick your poison. I am staying long cause that is all I do. All just my opinions. Good luck to you.
Can anyone make sense as to how ghost gets traded up and then the bottom falls out of it. Happens time and time again lately.
Regardless of market reaction that I won't even try to guess, I thought this was a very positive call and am pleased with the update. The most important thing to me is their current cash position. If a buyout is going to happen, will be in next 12 months.....If not, seems we have a clear path to US distribution. Almost makes me want to buy more! Just my opinions! Good luck all!
almost exact same report for Q2 2018 - WTF
And we find ourselves once again at one of the the most overhyped yet underwhelming days of the year.....the quarterly update. The day where it is revealed that some random small cap company ( in this case, Cormedix) has been keeping huge secrets of success waiting for this very day to announce stock spiking FDA or buyout news. Anyone who knows me knows I am a CRMD bull, but big spikes on earnings day is generally for companies with earnings! Yes, I hope some big reveal will come forth and push the PPS to $50, but my expectations are tempered. Let's hope the cash burn hasn't exploded while they work through FDA approval, let's hope for a little more clarity on already known FDA approval guidance, and let's hope they don't need cash in the forseeable future.....but I am not going to assume they are withholding information to reveal today. That's how shorts win after most small cap quarterly updates. Preying on the vulnerable hoping for a miracle. Good things are coming and I am long and bullish here! If you are a trader, then yes, you should pay attention.....if you are long, relax and enjoy the ride on the longest bumpiest road in the word in our Cormedix bus with no shocks!! I know there is no real pertinent info in this post and everything is just my opinion.....just had to get this off my chest. Good luck to all!
I dunno. Management can’t seem to pull their heads out of their asses long enough to generate value to shareholders. Last year and early this year were great. Right now, this blows.
for anyone w cash on the side - this is a yuge oppy
Thanks Rap! Hadn't seen that article. GLTU
Why yes ... yes it does. I've just been getting anxious. Cup and handle aside I just want to know when we can raise our glasses and celebrate lol.
Would you call that a cup and handle since April?
When is this thing going to get some legs and take off. Watching my grass grow is slightly more exciting lol.
News: $CRMD CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs
BERKELEY HEIGHTS, N.J., July 17, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced today that Dr. P...
Find out more CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs
CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs
https://finance.yahoo.com/news/cormedix-presents-fda-public-meeting-121500555.html?.tsrc=applewf
@hmuney Yes, Phoebe Mounts is presenting July 12th. Scroll down she is listed towards the end.
Public Meeting: Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD Pathway)
July 12, 2019 9:00 AM – 12:00 PM
U.S Food and Drug Administration White Oak Campus
Building 31, Room 1503 - Great Room 10903 New Hampshire Avenue Silver Spring, MD 20993
ABSTRACT
This meeting is to hear public comments on the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) draft guidance. This guidance provides information on the implementation of section 506(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 356(h), added by section 3042 of the 21st Century Cures Act.
Each public presentation is allotted 10 minutes. Five minutes are allotted following each presentation to offer an opportunity for the panel to ask clarifying questions. Please note that times may vary based on participation and other logistics and are subject to change.
8:00 AM – 9:00 AM 9:00 AM – 9:20 AM
9:20 AM – 9:30 AM 9:30 AM – 9:35 AM 9:35 AM – 9:45 AM
9:45 AM – 9:50 AM 9:50 AM – 10:00 AM 10:00 AM – 10:05 AM 10:05 AM – 10:15 AM
10:15 AM – 10:20 AM 10:20 AM – 10:30 AM
Registration
AGENDA
10:30 AM – 10:35 AM
Introductions and Opening Remarks
Ed Cox, MD, MPH, Director, OAP, OND, CDER, FDA
Public Presentation: John Rex, M.D. Chief Medical Officer, F2G Ltd.
Questions
Public Presentation: Thomas Walsh, M.D., Ph.D., Professor of Medicine, Pediatrics, Microbiology & Immunology, Cornell University
Questions
Public Presentation: Phoebe Mounts, Ph.D., General Counsel, Cormedix
Questions
Public Presentation: Colin McGoodwin, Infectious Diseases Society of America
Questions
Public Presentation: Jack Mitchell, Director of Health Policy, National Center for Health Research
What is YOUR Problem Lady!(I apologize to the Real ladies). You start out calling me a DOUCHE & I was right about News this week. Then you give me Grief for saying I was Correct and NOW you have the NERVE to call me a Braggart because I bought this stock over a year ago at .35. You are a Real Piece Of Work, also known as an AssH*$#.I will not be responding to an Imbecile like you Ms. Classless going forward!
Can anyone confirm if Phoebe Mounts is presenting this Friday (7/12) at the FDA LPAD Public Meeting?
https://www.federalregister.gov/documents/2019/04/02/2019-06390/limited-population-pathway-for-antibacterial-and-antifungal-drugs-public-meeting-request-for
The Eventbrite link below is directly from the FRN page linked above:
https://www.eventbrite.com/e/limited-population-pathway-for-antibacterial-and-antifungal-drugs-lpad-public-meeting-tickets-54015228001
For you ole timers in CRMD: If this does get FDA approval, as we expect, what are the projections for the pps, if some of you don't care to answer? Thanks in advance
ok then, god bless you and your 35s
braggart
LMAO! You are just PISSED I knew,what I was talking about, I said News was coming before 07/12 & I was right. UNLIKE YOU! I can wait for the FDA Approval. It IS a Process. I am WAY AHEAD of the game at .35.
You're DISMISSED!
hahaha - not much is a news was it? you want to take a bow for that?
Pretty good volume today so far, go CRMD !
Now, that's more like it! At least a good start anyway!
LOVE IT! It's GREAT when your prediction comes TRUE!!!!!! NO NEED FOR PUMPING CRMD, IT'S A WINNER!!!!!!
SHITFIRE!!! NO SECOND PHASE 3 NEEDED.
ITS ON LIKE DONKEY KONG!
For sure. Some trades were below $8.50
There were some nice buys made this morning for sure.
Ahem....APOLOGY ACCEPTED.
All news this morning encouraging but premarket down 5%??!!!!
thanks for the PM hmuney
HOLY CAT FIGHT!!!
WE ARE ALL FOR CRMD!
GIDDY UP, GANG!!!
THAT is NOT what I was or am waiting for.
Not sure why people are giving me sh*$ about NEWS and this stock. If you knew anything about CRMD you would through your DD KNOW that FDA News is coming any day now concerning Neutrolin.
JaneyH you could probably learn more about the Company by doing some DD so you would know what catalysts are coming concerning this stock and by checking out the other Boards such as StockTwits and/or Yahoo conversations boards instead of calling DOUCHE. AND if you want to BLOCK me please do....lol I am Long CRMD since June 2018. Bought in at .35.
@JaneyH Not that I owe you or anyone an explanation, but if you even DID your DD you would know that we are due to hear from the FDA concerning Neutrolin. I calculated when that should happen and I come up with no later than Friday July 12th, but I suspect BEFORE Friday, IMO (In My Opinion).
So we will wait and see! And there is no need for namecalling either. This is a Board to discuss stocks and our OPINIONS.
publishing preclinical data does not the needle move
@MsMoneyMaker1 was this what you were expecting:
www.globenewswire.com/news-release/2019/07/08/1879459/0/en/CorMedix-Announces-Publication-of-Taurolidine-Pre-Clinical-Oncology-Data-in-Investigational-New-Drugs-Journal.html
If not, please do share what you expect to move the needle more.
you sound like a pumping douche - what indication do you have that this is THE WEEK? you are one more douchey post from getting blocked
So READY for tomorrow. IMO, NEWS happens THIS Week for sure. Get ready to SOAR!
Followers
|
88
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2497
|
Created
|
08/11/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |